A citation-based method for searching scientific literature

Christopher P Hedges, Jordi Boix, Jagdish K Jaiswal, Bhoopika Shetty, Peter R Shepherd, Troy L Merry. Biomolecules 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series.
Emma L Mitchell, Peter Kar Han Lau, Chloe Khoo, David Liew, Jessica Leung, Bonnia Liu, Adam Rischin, Albert G Frauman, Damien Kee, Kortnye Smith,[...]. Eur J Cancer 2018
31
100

Pharmacological inhibition of PI3K reduces adiposity and metabolic syndrome in obese mice and rhesus monkeys.
Ana Ortega-Molina, Elena Lopez-Guadamillas, Julie A Mattison, Sarah J Mitchell, Maribel Muñoz-Martin, Gema Iglesias, Vincent M Gutierrez, Kelli L Vaughan, Mark D Szarowicz, Ismael González-García,[...]. Cell Metab 2015
60
100

PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor-positive breast cancer.
Ana Bosch, Zhiqiang Li, Anna Bergamaschi, Haley Ellis, Eneda Toska, Aleix Prat, Jessica J Tao, Daniel E Spratt, Nerissa T Viola-Villegas, Pau Castel,[...]. Sci Transl Med 2015
187
100

Quantitation of class IA PI3Ks in mice reveals p110-free-p85s and isoform-selective subunit associations and recruitment to receptors.
N Tsolakos, T N Durrant, T Chessa, S M Suire, D Oxley, S Kulkarni, J Downward, O Perisic, R L Williams, L Stephens,[...]. Proc Natl Acad Sci U S A 2018
15
100

Identification of variations in the human phosphoinositide 3-kinase p110delta gene in children with primary B-cell immunodeficiency of unknown aetiology.
S-T Jou, Y-H Chien, Y-H Yang, T-C Wang, S-D Shyur, C-C Chou, M-L Chang, D-T Lin, K-H Lin, B-L Chiang. Int J Immunogenet 2006
36
100

The Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic Diseases.
Edward Banham-Hall, Menna R Clatworthy, Klaus Okkenhaug. Open Rheumatol J 2012
62
100

Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner.
Ralitsa R Madsen, Rachel G Knox, Wayne Pearce, Saioa Lopez, Betania Mahler-Araujo, Nicholas McGranahan, Bart Vanhaesebroeck, Robert K Semple. Proc Natl Acad Sci U S A 2019
24
100

AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy.
M V Astle, K M Hannan, P Y Ng, R S Lee, A J George, A K Hsu, Y Haupt, R D Hannan, R B Pearson. Oncogene 2012
151
100

The PI3K Pathway in Human Disease.
David A Fruman, Honyin Chiu, Benjamin D Hopkins, Shubha Bagrodia, Lewis C Cantley, Robert T Abraham. Cell 2017
822
100

Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies.
Andres Forero-Torres, Radhakrishnan Ramchandren, Abdulraheem Yacoub, Michael S Wertheim, William J Edenfield, Paolo Caimi, Martin Gutierrez, Luke Akard, Carolina Escobar, Justin Call,[...]. Blood 2019
39
100



PI3Kδ as a Novel Therapeutic Target in Pathological Angiogenesis.
Wenyi Wu, Guohong Zhou, Haote Han, Xionggao Huang, Heng Jiang, Shizuo Mukai, Andrius Kazlauskas, Jing Cui, Joanne Aiko Matsubara, Bart Vanhaesebroeck,[...]. Diabetes 2020
7
100

Active PI3K pathway causes an invasive phenotype which can be reversed or promoted by blocking the pathway at divergent nodes.
Jeffrey J Wallin, Jane Guan, Kyle A Edgar, Wei Zhou, Ross Francis, Anthony C Torres, Peter M Haverty, Jeffrey Eastham-Anderson, Sabrina Arena, Alberto Bardelli,[...]. PLoS One 2012
38
100

Treatment of Chronic Lymphocytic Leukemia.
Jan A Burger. N Engl J Med 2020
55
100


Characterization of Novel PI3Kδ Inhibitors as Potential Therapeutics for SLE and Lupus Nephritis in Pre-Clinical Studies.
Philipp Haselmayer, Montserrat Camps, Mathilde Muzerelle, Samer El Bawab, Caroline Waltzinger, Lisa Bruns, Nada Abla, Mark A Polokoff, Carole Jond-Necand, Marilène Gaudet,[...]. Front Immunol 2014
16
100

Role of phosphoinositide 3-kinase signaling in autoimmunity.
Jean S Oak, David A Fruman. Autoimmunity 2007
12
100

PI3Kαδ Inhibitor Combined With Radiation Enhances the Antitumor Immune Effect of Anti-PD1 in a Syngeneic Murine Triple-Negative Breast Cancer Model.
Won Ick Chang, Min Guk Han, Mi Hyun Kang, Ji Min Park, Eric Eunshik Kim, Junhyung Bae, Soyeon Ahn, In Ah Kim. Int J Radiat Oncol Biol Phys 2021
2
100

Transcription of PIK3CD in human brain and schizophrenia: regulation by proinflammatory cytokines.
Veronica L Hood, Ralph Berger, Robert Freedman, Amanda J Law. Hum Mol Genet 2019
5
100

Discovery and in vivo evaluation of (S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine (AMG319) and related PI3Kδ inhibitors for inflammation and autoimmune disease.
Timothy D Cushing, Xiaolin Hao, Youngsook Shin, Kristin Andrews, Matthew Brown, Mario Cardozo, Yi Chen, Jason Duquette, Ben Fisher, Felix Gonzalez-Lopez de Turiso,[...]. J Med Chem 2015
55
100

Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer.
Khaled Ali, Dalya R Soond, Roberto Pineiro, Thorsten Hagemann, Wayne Pearce, Ee Lyn Lim, Hicham Bouabe, Cheryl L Scudamore, Timothy Hancox, Heather Maecker,[...]. Nature 2014
327
100

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
Tsukasa Shibue, Robert A Weinberg. Nat Rev Clin Oncol 2017
100

Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial.
S Dent, J Cortés, Y-H Im, V Diéras, N Harbeck, I E Krop, T R Wilson, N Cui, F Schimmoller, J Y Hsu,[...]. Ann Oncol 2021
18
100

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.
Tanya I Coulter, Anita Chandra, Chris M Bacon, Judith Babar, James Curtis, Nick Screaton, John R Goodlad, George Farmer, Cathal Laurence Steele, Timothy Ronan Leahy,[...]. J Allergy Clin Immunol 2017
206
100

Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration.
Mariona Graupera, Julie Guillermet-Guibert, Lazaros C Foukas, Li-Kun Phng, Robert J Cain, Ashreena Salpekar, Wayne Pearce, Stephen Meek, Jaime Millan, Pedro R Cutillas,[...]. Nature 2008
364
100

Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue.
Kamal D Puri, Teresa A Doggett, Jason Douangpanya, Yonghao Hou, William T Tino, Tim Wilson, Thomas Graf, Elizabeth Clayton, Martin Turner, Joel S Hayflick,[...]. Blood 2004
169
100

Genomic Determinants of PI3K Pathway Inhibitor Response in Cancer.
Britta Weigelt, Julian Downward. Front Oncol 2012
58
100

Combining a PI3K inhibitor with a PARP inhibitor provides an effective therapy for BRCA1-related breast cancer.
Ashish Juvekar, Laura N Burga, Hai Hu, Elaine P Lunsford, Yasir H Ibrahim, Judith Balmañà, Anbazhagan Rajendran, Antonella Papa, Katherine Spencer, Costas A Lyssiotis,[...]. Cancer Discov 2012
275
100

Time course and management of key adverse events during the randomized phase III SOLAR-1 study of PI3K inhibitor alpelisib plus fulvestrant in patients with HR-positive advanced breast cancer.
H S Rugo, F André, T Yamashita, H Cerda, I Toledano, S M Stemmer, J C Jurado, D Juric, I Mayer, E M Ciruelos,[...]. Ann Oncol 2020
23
100

Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.
V Koneti Rao, Sharon Webster, Virgil A S H Dalm, Anna Šedivá, P Martin van Hagen, Steven Holland, Sergio D Rosenzweig, Andreas D Christ, Birgitte Sloth, Maciej Cabanski,[...]. Blood 2017
129
100

Critical influences on the pathogenesis of follicular lymphoma.
Ralf Küppers, Freda K Stevenson. Blood 2018
27
100

Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
Klaus Okkenhaug, Antonio Bilancio, Géraldine Farjot, Helen Priddle, Sara Sancho, Emma Peskett, Wayne Pearce, Stephen E Meek, Ashreena Salpekar, Michael D Waterfield,[...]. Science 2002
722
100

Alveolitis in severe SARS-CoV-2 pneumonia is driven by self-sustaining circuits between infected alveolar macrophages and T cells.
Rogan A Grant, Luisa Morales-Nebreda, Nikolay S Markov, Suchitra Swaminathan, Estefany R Guzman, Darryl A Abbott, Helen K Donnelly, Alvaro Donayre, Isaac A Goldberg, Zasu M Klug,[...]. bioRxiv 2020
6
100

Cancer immunotherapy-associated hypophysitis.
Cinzia Solinas, Michele Porcu, Pushpamali De Silva, Marco Musi, Sandrine Aspeslagh, Mario Scartozzi, Karen Willard-Gallo, Stefano Mariotti, Luca Saba. Semin Oncol 2018
28
100

First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer.
Sarah Blagden, Aurelius Omlin, Debra Josephs, Chara Stavraka, Andrea Zivi, David J Pinato, Alan Anthoney, Shaun Decordova, Karen Swales, Ruth Riisnaes,[...]. Clin Cancer Res 2014
29
100


Y Chromosome LncRNA Are Involved in Radiation Response of Male Non-Small Cell Lung Cancer Cells.
Tayvia Brownmiller, Jamie A Juric, Abby D Ivey, Brandon M Harvey, Emily S Westemeier, Michael T Winters, Alyson M Stevens, Alana N Stanley, Karen E Hayes, Samuel A Sprowls,[...]. Cancer Res 2020
6
100

Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations.
Turgut Dogruluk, Yiu Huen Tsang, Maribel Espitia, Fengju Chen, Tenghui Chen, Zechen Chong, Vivek Appadurai, Armel Dogruluk, Agna Karina Eterovic, Penelope E Bonnen,[...]. Cancer Res 2015
81
100

Ex vivo Akt inhibition promotes the generation of potent CD19CAR T cells for adoptive immunotherapy.
Ryan Urak, Miriam Walter, Laura Lim, ChingLam W Wong, Lihua E Budde, Sandra Thomas, Stephen J Forman, Xiuli Wang. J Immunother Cancer 2017
31
100

Parsaclisib Is a Next-Generation Phosphoinositide 3-Kinase δ Inhibitor with Reduced Hepatotoxicity and Potent Antitumor and Immunomodulatory Activities in Models of B-Cell Malignancy.
Niu Shin, Matthew Stubbs, Holly Koblish, Eddy W Yue, Maxim Soloviev, Brent Douty, Kathy He Wang, Qian Wang, Mingming Gao, Patricia Feldman,[...]. J Pharmacol Exp Ther 2020
9
100

A mouse model of Proteus syndrome.
Marjorie J Lindhurst, Lauren R Brinster, Hannah C Kondolf, Jasmine J Shwetar, Miranda R Yourick, Henoke Shiferaw, Kim M Keppler-Noreuil, Gene Elliot, Cecilia Rivas, Lisa Garrett,[...]. Hum Mol Genet 2019
6
100

A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome.
Maria Juarez, Nieves Diaz, Geoffrey I Johnston, Saba Nayar, Andrew Payne, Eric Helmer, Dionne Cain, Paulette Williams, Valerie Devauchelle-Pensec, Benjamin A Fisher,[...]. Rheumatology (Oxford) 2021
7
100

Optimization of Novel Indazoles as Highly Potent and Selective Inhibitors of Phosphoinositide 3-Kinase δ for the Treatment of Respiratory Disease.
Kenneth Down, Augustin Amour, Ian R Baldwin, Anthony W J Cooper, Angela M Deakin, Leigh M Felton, Stephen B Guntrip, Charlotte Hardy, Zoë A Harrison, Katherine L Jones,[...]. J Med Chem 2015
76
100

Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.
Anniek B van der Waart, Noortje M P van de Weem, Frans Maas, Cynthia S M Kramer, Michel G D Kester, J H Frederik Falkenburg, Nicolaas Schaap, Joop H Jansen, Robbert van der Voort, Luca Gattinoni,[...]. Blood 2014
71
100


Membrane metallo-endopeptidase mediates cellular senescence induced by oncogenic PIK3CAH1047R accompanied with pro-tumorigenic secretome.
Xue-Ling Liu, Jia-Li Liu, Yi-Chao Xu, Xi Zhang, Yu-Xiang Wang, Li-Hua Qing, Wei Guo, Jian Ding, Ling-Hua Meng. Int J Cancer 2019
3
100

PI3Kδ and primary immunodeficiencies.
Carrie L Lucas, Anita Chandra, Sergey Nejentsev, Alison M Condliffe, Klaus Okkenhaug. Nat Rev Immunol 2016
149
100

PI3 kinase δ is a key regulator of synoviocyte function in rheumatoid arthritis.
Beatrix Bartok, David L Boyle, Yi Liu, Pingda Ren, Scott T Ball, William D Bugbee, Christian Rommel, Gary S Firestein. Am J Pathol 2012
76
100

Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K.
Mary Ellen Conley, A Kerry Dobbs, Anita M Quintana, Amma Bosompem, Yong-Dong Wang, Elaine Coustan-Smith, Amber M Smith, Elena E Perez, Peter J Murray. J Exp Med 2012
138
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.